View Article

Abstract

In recent years, research on the beneficial effects of winter cherry (Withania somnifera) for health, commonly called ashwagandha, has greatly increased. Studies show its positive effects on various aspects of human health, such as reducing stress, improving sleep, and acting as a natural sedative and adaptogen. It has also been linked to antimicrobial, anti-inflammatory, heart-protective, along with its anti-diabetic qualities, along with potential positive effects for the reproduction process health and hormone regulation. Importantly, growing evidence highlights Ashwagandha’s role in osteoarthritis (OA), where it helps reduce joint pain, swelling, and stiffness by lowering inflammation and protecting cartilage. With this expanding research, Ashwagandha is emerging as a promising natural treatment for osteoarthritis as well as several other health issues. This review summarizes the latest evidence, providing an overview of Ashwagandha’s possible applications with a special focus on osteoarthritis.

Keywords

Withania somnifera , Solanaceae, Osteoarthritis, Ashwagandha, Knee osteoarthiritis

Introduction

In the conventional medical system, many diseases have been treated utilized plants or plants product. People are interested in using herbal plant because their distinctive therapeutic properties, common causes, cost viability & safe result1. Ashwagandha is very popular & widely herb in India. It used in many traditional medicines like Ayurveda, Siddha, Sowa Rigpal, Unani and homeopathy. People use it because it has much health benefits2. Ashwagandha (Withania somnifera ) also called Indian ginseng or winter berry. It is member of solanaceae (night shade plant family)3. Ashwagandha’s name comes from “Ashwa” means horse and it is thought that eating the root could give an individual strengths & energy like the horse. "Gandha" is the second part that means smell which alludes to this strong scent of the plants raw root4. from ancient time, it has been used In Ayurveda to make the neurological system strong. This is because of The adaptogenic properties and therapeutic value, known as “rasayana”5. Its use in Indian medicine is almost 3000 years old. The root has been utilized as a diuretic, tonic, narcotic, and aphrodisiac, deworming medicine together with a stimulant.6   It grows Naturally in India, but is also grown in the Himalayan areas, Mediterranean nations, the Canary Islands, Africa, the Good Hope Cape and Australia7.  in ayurveda, this medicine is made by fresh roots boiled with milk. Sometimes, the roots are crushed into a fine powder known as “Churn” and mixed with milk, honey or water. To improve health and increase lifespan, other regions of the plants like Additionally, berries, seeds, shoots, and leaves are used8. In ayurveda, it is classified Being a Rasayana, which means it helps in improving physical and mental health, restoring the anatomy, and increasing lifespan. That is well known for its immune modulating activity9. This plant has many properties like antioxidant, immunomodulator, anti-diabetic, anti-inflammatory, anti-stress, antimicrobial and cardio protective. It can also improve role of endothelium, lower reactive oxygen species as well as reduce again effects.  It is effective in health problem such anxiety, stress, arthritis, epilepsy, fatigue, neurodegenerative disease, thyroid disorder and skin diseases10. In recent years, people have shown more interest in ashwagandha's health advantages, especially for managing stress, improving memory and brain function boosting physical strength. Research shows that ashwagandha could protect the brain, help with OCD, and it has anti-inflammatory properties. immune-boosting and antibacterial effect. It may also be useful in treating infertility, cancer, and diabetes. According to certain research, ashwagandha can protect the heart and may help in treating sleep problems.

Health benefits of Ashwagandha

Although Ashwagandha shows many possible health benefits, more investigation is required to fully know how it works and how effective it is in the treatment of different health problems. In this document, we review the available studies on Ashwagandha, mainly focusing on its possible advantages for lowering stress, improving brain function as well as boosting bodily performance11.

Among its many uses, Ashwagandha is also being studied for its potential role in joint health, including osteoarthritis. Therefore, this project focuses more on its possible applications in osteoarthritis.

ASHWAGANDHA

Synonyms: Roots of Withania, Ashwagandha, Indian ginseng, Cherry for winter.

Biological Source: It is made up of Withania somnifera Dunal's dried roots and stem bases, which are members of the Solanaceae family.

Drug profile:

Withania somnifera  Linn Dunal, or ashwagandha, grows in India's arid and subtropical regions. It is widely distributed throughout northwest India, particularly in Bombay, Gujarat, Rajasthan, Madhya Pradesh, Uttar Pradesh, Punjab, and a few mountainous regions like Himachal Pradesh and Jammu, which reach elevations of 1500 meters. This species is widely spread to numerous other nations, including Poland, Afghanistan, Israel, Egypt, Jordan, Morocco, Spain, the Canary Islands, Eastern Africa, Wingo, South Africa, and Pakistan12.

Active constituents:

Ashwagandha has many natural plant chemicals. The types of compounds found can change depending on where the plant is grown. The most important compound for its health effects are withanolides & alkaloids.

Sub types:

  1. Withanolides: these are special compound with a structure similar to steroids. Some examples are withanone, withaferin A & Withanolides A.
  2. Alkaloids: these include chemical like withanine, somniferine, tropine, choline and anaferine.
  3. Flavonoids: these are antioxidant compound such as quercetic & rutin13.

Ashwagandha also has:

  • Withanolide glycoside (with added sugar groups) such as sitoindoside 1x & x.
  • Steroidal saponins, like sitoindoside vii & viii.
  • Other compound like saponins, cocumarins (scopoletin), lipids, carbohydrates, fatty acids, sterols, chlorogenic acid, and resins14.

Structure of an examples of a withanolide active compound in Ashwagandha15.

The natural chemicals in Withania somnifera  (Ashwagandha) are of great interest to research. Scientists have studied this plant and found may tapes of compound, such alkaloids, flavonoids, and steroidal lactones & tannis. From its leaves, roots & berries 138 withanolides, over 13 alkaloids, and a number of sitoindosides (a type of withanolide that has found a glucose molecule that is joined at carbon 27. Changes in the environment can also lead the plant to produce new or different chemical compound16.

The primary chemical is withanolides found in the plant (mostly in the roots and leaves). There amount is usually 0.001-0.5% of the dry weight of the plant.

  • They are a type of steroidal lactone (special chemical structure).
  • In their structure, two carbons atoms (c-22 and c-26) are changed to form 0 ring of six lactones.
  • It is known as a withanolide skeleton (scientifically described) as 22 hydroxyergostern-26-oic-acid 122-lactone).
  • Changes in carbon skeleton or side chains create different types of withanolides plant naturally make these variations with the help of enzymes that can oxidize (add oxygen) to many parts of the steroid nucleus.
  • Withanolides are very similar to another group of compounds called ergesterone type steroids, both having a side chain with a lactone or lactrol ring17.

Plant part

Bioactive compound

Uses

Leaves

Alkaloids, Flavonoids

Antipyretic (redce fever)

Analgesic (Pain reliver)

Antimicrobial (helps wound healing, skin infection when applied as paste)

Fruits

Withanosides, polphenols

Diuretic (helps in water retention)

Laxative (mild)

Used in ayurvedic preparation for constipation and hormonal bance

Seeds

Fatty acids, steroids

Used in treating parasitic infections

Stem

Triterpenoids, Sitoindosides

General tonic

Antioxidant properties

Immunity booster

 

Biological Activity:

1. Anti-Inflamattory & Immunomodulatory Effects:

Many of the disease states of inflammatory origins such as diabetes, cancer, neurological disease, pulmonary disease, cardiac disease, and autoimmune disease are studied in relation to Withania somnifera . Before clinical This plant also controls the activity and death of cells and inflammation by suppressing harmful indicators such as cytokines (e.g., IL-6 and TNF-a), nitric oxide, and reactive oxygen species. Meanwhile, experiments on mice with lupus indicated that ashwagandha root powder could have blocking actions in situations such as inflammation of the kidneys and proteinuria18. Scientists are also investigating how effective ashwagandha is against rheumatoid arthritis. In an animal study, rats were given Withania somnifera  root powder by mouth three weeks. Days, an hour before the CFA (complete Freund's adjuvant) injection that provoked inflammation. Phenylbutazone was also given to the rats of the positive control group. There was an evident reduction of inflammation, and there were alterations of certain serum proteins like prealbumin, α2 glycoprotein, and acute phase protein α119.

2. Antibacterial & Antimicrobial properties:

Although well known, resistance of germs to drugs is a large and increasing issue. In the past years, there has been a large rise in infections from bacteria that do not respond to drugs. We understand that irresponsible and frequently Overuse of antibiotics has led to the development of drug-resistant bacteria, and at times, these drugs are of no use. So, ashwagandha seems like a beneficial supplement in addition to medicine for the treatment of bacterial infections. Though effective, there are few drugs that are prescribed for bacterial infections that do not have harmful side effects because they are toxic. Ashwagandha hardly ever has adverse effects and is a safe non-toxic plant. In the experiments that have been done, it has has been proved effective in inhibiting the progress of Enterococcus species and methicillin-resistant Staphylococcus aureus20. Some of its properties are crucial to how it operates to combat germs. It can be toxic to cells, it can mute genes, and it can alter the workings of the immune system by increasing its activity21. found that the W. somnifera extract demonstrated greater antibacterial activity against P. aeruginosa. Experiments on how Ashwagandha extract fights against bacteria were carried out by the use of shape analysis and membrane stability tests. demonstrated that they act by damaging P. aeruginosa's cell membrane. Moreover, mouse experiments confirm that extracts of Withania somnifera , at higher concentrations specifically, are effective against malaria because parasites are greatly lowered22.

3. Huntington’s Diseases Management:

Huntington's disease is not curable. Our drugs today merely give relief from the symptoms but decrease the rate at which the disease advances. Since the disease is inherited as an autosomal dominant disorder, half of the offspring will inherit the allele responsible for the disease.  Huntingtin's (htt) protein experiences a conformation shift into its insoluble state because of an IT15 gene mutation on chromosome 4.  Rapid neuron death occurs from the aggregation of the mutant huntingtin protein's N-terminal portion that has expanded polyglutamine repeats. As a consequence, dopamine, GABA, serotonin, and cholinergic neurons become imbalanced23.

A potent neurotoxin is 3-nitroproprionic acid (3-NP). It generates oxidative and nitrosative stress, halts the complex II of the electron transport chain of mitochondria (which causes an energy-deficient state), and causes biochemical and Behaviors that resembled those of Huntington's disease. An animal model of Huntington's disease symptoms was induced by giving an injection of 3-NP. The plant being studied has antioxidants. It was found that taking ashwagandha extract for a long-time improved health and movement. There was a decrease in lipoperoxidation, a Reduction of lactate and nitrate dehydrogenase levels, elevation of catalase and superoxide dismutase levels, and unbarring of the mitochondrial complex result in the recovery of ATP synthesis. Action of 100 mg/kg and 200 mg/kg was dose dependent24.

4. Enhancement of muscle strength:

Supplementing with ashwagandha has been found to substantially enhance strength of muscles and enhance recovery of muscles. In a study, we enrolled young men who were otherwise healthy. They received 300 mg of oral Withania somnifera  root extract two times each day. For eight weeks each day, these men also engaged in physical activity. Participants adhered tightly to a resistance training regimen according to guidelines issued by the National Strength and Conditioning Association (NSCA). Treated individuals experienced a gain of arm and chest muscle size and a definite gain of strength of muscles. The plasma creatine kinase levels stabilized, indicative of significantly lower exercise-inspired muscle damage present in patients who received ashwagandha as compared to those who received a placebo. In addition, the treated group also experienced a large reduction in body fat as well as a visible rise in testosterone25.

5. Cardioprotective Effect:

Albino rats were used to examine the protective effects of ashwagandha against isoprenaline treatment-induced heart injury. Low levels of glutathione and weaker activity of catalase, creatinine phosphokinase, superoxide dismutase, etc., existed. and lactate dehydrogenase were found in the rats given Withania somnifera  treatment.  Levels of lipid peroxidation also sharply declined.  These findings suggest that, in a rat model of isoprenaline-induced necrosis, Withania somnifera  has a cardioprotective effect26. These experiments used rats when cardiac ischemia was induced.  Prolonged cardiac necrosis, an oxidative antioxidant disorder, including elevation oflipoperoxidation, followed from this. According to histopathological examinations, revealed ischemia-triggered heart damage is significantly alleviated upon use of Withania somnifera .  Owing to its anti-apoptotic properties and restoration of the oxidative balance, ashwagandha confers cardioprotection27.

Therapeutic Potential of New Diseases: 

1. Breast cancer (Chemotherapy fatigue):

A clinical study published in 2013 looked at whether A powdered extract of ashwagandha root (from Himalaya Drug Co., New Delhi, India) could reduce Chemotherapy-induced tiredness and improve standard of living in breast cancer patients. Patients receiving chemotherapy for breast cancer were divided alternately separated into two groups: 50 patients in the study group and 50 patients in the control group. The research team took 500mg of ashwagandha dry extract three times a day during all six chemotherapy cycles. The patients who took ashwagandha felt less exhausted and had a improved standard of living compared to the group under control28.

2. Osteoarthritis:

A clinical trial lasting six weeks conducted in 2012 tested An Ayurvedic formula's safety for treating osteoarthritis in the knees. The formula (presentation and the maker did not mention) included Zingiber officinale, ginger, and powdered ashwagandha root, Zingiberacea), Guduchi or Indian tinospora (Tinospora, cardifolia, Menispermaceae), Furthermore, Tribulus (Tribulus terrestris, Zygophyllaceous). The study found Not at all serious side effects and none of the individuals involved stopped the trial because of any drug-related problems29.

3. Hypothyroidism:

Studies in mice showed that ashwagandha can raise thyroxine (T4) levels. Because of this, thyroid function was checked in a clinical trial on 60 patients with bipolar disorder, a condition often linked with thyroid problems.

In this trial, 10 had abnormal thyroid result:

Three individuals taking ashwagandha already had thyroid tests that were abnormal at the beginning (one had high TSH, one had high T3 Lithium caused one to have low T4). By At the study's conclusion, all three had normal Thyroid results, and their T4 levels increased by 7-24%.

Seven patients in the placebo group also had abnormal thyroid tests at the beginning. By the end, six had a drop at T4, with just one displaying an increase30.

As of 2018, another clinical trial was carried out with Fifty patients having slight hypothyroidism (TSH 4.5-10IU/L). it was A placebo-controlled, double-blind research. For eight weeks, patients received 600 mg of ashwagandha extract every day.

Result showed:

After 4 weeks, TSH, T4 and T3 all improved.

After 8 weeks, the improvements were 17.4% in TSH, 19.6% in T4, and 41.5% in T3.

In the placebo group, there were no meaningful changes31.

Ashwagandha may improve thyroid function because:

It affects the HPA axis (Stress, system), which is connected to the HPT axis (Thyroid system). high cortisol can reduce thyroid hormones, and ashwagandha helps prevent this. It has dopaminergic and anti-inflammatory effects that influence both systems. Animal studies also show it might directly affect thyroid activity and hormone metabolism So far, no more human trials have been done. But these positive results, along with the link between stress and thyroid problems, suggest that ashwagandha could be useful for people with subclinical hypothyroidism32.

4. In fertility in men:

In a 2013 clinical trial, infertile men were studied at King George's Medical University's infertility center in Lucknow, India. There were three groups:

  • 60 men with similar semen but unexplained infertility,
  • 60 men with a low number of sperm but typical sperm shape,
  • 60 men with a typical number of sperm and shape but low sperm movement (motility).

A control group included 50 healthy men of the same age who had normal semen and had fathered at least one child.

The patients within the research group were given 5 grams of Powdered ashwagandha root (source from the Central Council for Unani Medicine Research, located in New Delhi: shade- dried up and finely ground) mixed with milk every day three months.

Semen samples were gathered and tested. The result showed that ashwagandha helped to balance important markers in the seminal plasma and could improve fertility by acting on metabolism, enzymes and hormones33.

5. Sexual dysfunction (Male & Female):

Ashwagandha is often believed to improve sexual health, but research evidence is limited, in women, one small study showed taking 600 Ashwagandha milligrams extract daily for two months became better sexual function in those who had sexual problems. However, in men, results have not been supportive34. A Research on Men who suffer from erectile dysfunction have no benefits from taking 6000 ashwagandha powder milligrams daily for 2 months as contrasted with placebo35. An additional study in men aged 40-70 with exhaustion as well showed There is no boost in sexual health, even though testosterone levels increased when they consumed 240 milligrams of ashwagandha extract per day for 2 months36.

6. Insomnia / Sleep:

Withania somnifera  is the Latin name for ashwagandha, shows its connection to go to sleep, as “somnifera” means “promoting sleep.” The plant is believed to refresh the neurological system, reduce tension, and improve rest without causing drowsiness37.

In recent years, five high-quality clinical studies (double-blind, placebo-controlled) have confirmed that ashwagandha helps improve sleep. These studies included healthy adults, stressed adults, people with anxiety and insomnia, those with only insomnia, people with poor-quality sleep, and elderly individuals38.

Different methods were used to measure sleep, such as actigraphy and sleep surveys ((A gadget

worn like a watch to track sleep patterns). Both showed improvements, with sleep quality increasing by 30–72%. The benefits were usually greater in people who already had sleep problems39.

Most studies gave participants 600 Ashwagandha milligrams root extract per day. One study utilized a mix of root and leaf extract at 120 mg per day, which gave the best results (72% improvement in sleep quality). Treatments lasted 6–12 weeks, and improvements appeared gradually over time40. Ashwagandha’s stress-relieving effects likely play a major function in enhancing sleep. Animal research also recommend ashwagandha affects the GABA system in the brain, which helps calm the nervous system and supports better sleep41.

7. Emerging disease (ex-covid 19):

COVID-19, or coronavirus disease 2019, is a virus infection that spread worldwide after December 2019, creating an urgent need for new treatments42.

Research on Withania somnifera  (WS, Ashwagandha) shows that some of its natural compounds may help fight COVID-19:43.

A study predicted that Withanone can attach to the COVID-19 spike protein's receptor-binding domain (RBD) and the human ACE-2 receptor. This may block the virus from entering cells. It may also stop the virus from multiplying by reducing spike glycosylation.

Computer-based studies found that 2,3-Dihydrowithaferin 27-Deoxy-14-hydroxywithaferin and A can block both the spike protein with NSP3 protein of the virus44.

Four other WS compounds were found to block the envelope (E) protein of COVID-19 by binding to its pore region, which may slow down viral growth.

WS's aqueous root extract also lowered Death and stress rates Tilapia Lake virus (TiLV) is the cause, showing broader antiviral effects45.

Other WS compounds like Along with rutin and isochlorogenic acid B, quercetin-3-rutinoside-7-glucoside was effective even more effective than withanone and withanolide against the main SARS protease-CoV-246.

Molecular docking research showed that Withanoside II, Sitoindoside, Withanoside IV, and Withanoside V attach strongly to the primary SARS-CoV-2 protease, suggesting strong antiviral activity47.

Therapeutic potential in Osteoarthritis: 

Osteoarthritis (OA) is a condition that impacts the joints, especially the ones that move. It happens when the smooth cartilage covering the bones wears down. Along with this, changes occur in the bone, new bony growths (osteophytes) may form, and the joint can become inflamed, leading to reduced normal movement. The problem usually starts with small or large injuries to the joint, which trigger abnormal repair processes and disturb the normal balance of joint tissues48.

Overview of healthy and osteoarthritis joint

QA is one of the primary causes of long-term impairment, mainly because of joint pain, which is the most common complaint. In knee QA, pain often starts only during activity but later becomes more constant and long-lasting. Along with pain, stiffiness is also common, making it difficult to carry out daily activities. The more severe the pain, the more the person’s movements and functions are restricted. Apart from affecting health, OA also creates a significant financial and social burden49.

The chances of developing osteoarthritis increase due to several factors. These include family history (genetics), lifestyle habits, natural changes in the body like age and gender, and health problems such as obesity and high blood pressure50.

For joint pain, doctors often use medicines like NSAIDs, painkillers, and corticosteroids. However, NSAIDs can cause heart and stomach problems, and strong painkillers may lead to addiction, which worries both doctors and patients. Studies have also shown that steroid injections in the joint can sometimes speed up osteoarthritis, cause small bone fractures, lead to bone tissue damage, or even rapid joint breakdown. Because of these risks, safer treatment options are needed. The use of natural medicine has been around for a while to manage osteoarthritis and usually cause fewer side effects than standard drugs. Research also suggests that some herbs may help slow the worsening of the disease through different biological actions51.

Some commonly studied herbal extracts include Boswellia serrata, Cortex Eucommia, Matricaria chamomilla, and Tripterygium wilfordii root & Withania somnifera 52.

Withania somnifera , also called Ashwagandha, is a well-known herb in Ayurveda. It is mainly used for its pain-relieving as well as anti-inflammatory qualities. Studies have indicated that extracts of this plant can block certain molecules in the body (such as IL-1β, IL-12, and TNF-α) by reducing the activity of specific pathways (AP-1 and NF-κB). It can also protect collagen (the main protein in tendons and cartilage) from breaking down by lowering the action of collagenase enzymes. In animal studies, Ashwagandha treatment reduced swelling, redness, joint deformity, and stiffness. Its effects may be due to lowering harmful molecules like MMP-8, ROS, TNF-α, IL-1β, and IL-6, while increasing protective ones like IL-1053.

Sumantran and colleagues found that water extracts of Ashwagandha could protect damaged cartilage in people with osteoarthritis by reducing collagenase activity. Clinical studies also support its pain-relieving benefits in knee osteoarthritis. In a 12-week study, patients taking 125 mg or 250 mg of extract from ashwagandha reported less pain, stiffness, swelling, and disability compared to those on placebo. The higher dose worked faster (within 4 weeks), improved doctors’ overall assessments, and reduced the need for painkillers like paracetamol54.

A mixture of Maharasnadi Kwath, Bala oil, and Ashwagandha oil can be gently warmed and used for massage on affected joints. Massaging in circular motions for 10–15 minutes allows the herbal oils, including Ashwagandha, to penetrate the skin, helping to reduce pain and inflammation. The oil should remain on the skin for at least 30 minutes, and additional warmth—like a warm towel or compress—can enhance its effect. This therapy can be done once or twice daily, ideally before a bath or bedtime. While Ashwagandha contributes anti-inflammatory and pain-relieving effects, individual outcomes may vary, so guidance from a qualified Ayurvedic practitioner is recommended55.

CONCLUSION:

Ashwagandha plant Withania somnifera  is a well-known medicinal plant valued for its anti-inflammatory, antioxidant, and adaptogenic properties. While historically, it has been utilized to increase strength and vitality, modern research shows its special potential in osteoarthritis (OA) management. Clinical and experimental studies report Ashwagandha also lowers joint pain, rigidity, swelling, and disability by lowering inflammatory mediators and protecting cartilage from damage. Thus, Ashwagandha acts as a safe and natural therapeutic option that bridges ancient Ayurveda with modern medicine, offering promising benefits in improving joint health and managing osteoarthritis.

REFERENCES

  1. Naik GH, Priyadarsini KI, Satav JG, Banavalikar MM, Sohoni DP, Biyani MK, Mohan H. Comparative antioxidant activity of individual herbal components used in Ayurvedic medicine. Phytochemistry. 2003 May 1;63(1):97-104.
  2. Abdel-Wahhab KG, Mourad HH, Mannaa FA, Morsy FA, Hassan LK, Taher RF. Role of ashwagandha methanolic extract in the regulation of thyroid profile in hypothyroidism modeled rats. Molecular biology reports. 2019 Aug 15;46(4):3637-49.
  3. Monograph (2004) Withania somnifera . Altern.Med. rev.9/. 211-214 NMI -ashwagandha – A- Revi 1/pg
  4. Singh N, Bhalla M, de Jager P, Gilca M. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. African journal of traditional, complementary and alternative medicines. 2011;8(5S).
  5. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D, Langade DG. Efficacy and safety of Ashwagandha (Withania somnifera ) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus. 2019 Sep 28;11(9).
  6. Po?umackanycz M, Forencewicz A, Weso?owski M, Viapiana AA. The plant with proven health-promoting properties. Farm. Pol. 2020; 76:442-7.
  7. Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J. Steroidal lactones from Withania somnifera , an ancient plant for novel medicine. Molecules. 2009 Jul 3;14(7):2373-93.
  8. Zahiruddin S, Basist P, Parveen A, Parveen R, Khan W, Ahmad S. Ashwagandha in brain disorders: A review of recent developments. Journal of ethnopharmacology. 2020 Jul 15; 257:112876.
  9. Matsuda H, Murakami T, Kishi A, Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera  DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorganic & medicinal chemistry. 2001 Jun 1;9(6):1499-507.
  10. Bhattacharya SK, Satyan KS, Shibnath Ghosal SG. Antioxidant activity of glycowithanolides from Withania somnifera .
  11. John J. Therapeutic potential of Withania somnifera : A report on phyto-pharmacological properties. Int. J. Pharm. Sci. Res. 2014 Jun 1;5(6):2131-48.
  12. Pandit S, Chang KW, Jeon JG. Effects of Withania somnifera  on the growth and virulence properties of Streptococcus mutans and Streptococcus sobrinus at sub-MIC levels. Anaerobe. 2013 Feb 1; 19:1-8.
  13. John J. Therapeutic potential of Withania somnifera : A report on phyto-pharmacological properties. Int. J. Pharm. Sci. Res. 2014 Jun 1;5(6):2131-48.
  14. Dutta R, Khalil R, Green R, Mohapatra SS, Mohapatra S. Withania somnifera  (Ashwagandha) and withaferin A: Potential in integrative oncology. International journal of molecular sciences. 2019 Oct 25;20(21):5310.
  15. https://www.researchgate.net/figure/Chemical-structures-of-phytochemicals-from-Withania-somnifera-from-wwwChemSpidercom_fig3_354890919
  16. Atta-ur-Rahman AU, Samina Abbas SA, Dur-e-Shahwar DE, Jamal SA, Choudhary MI. New withanolides from Withania spp.
  17. Tursunova RN, Maslennikova VA, Abubakirov NK. Withanolides in the vegetable kingdom. Chemistry of natural compounds. 1977 Mar;13(2):131-8.
  18. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera , the Indian Ginseng. Cellular and molecular life sciences. 2015 Dec;72(23):4445-60.
  19. Rasool M, Varalakshmi P. Immunomodulatory role of Withania somnifera  root powder on experimental induced inflammation: An in vivo and in vitro study. Vascular pharmacology. 2006 Jun 1;44(6):406-10.
  20. Bisht P, Rawat V. Antibacterial activity of Withania somnifera  against Gram-positive isolates from pus samples. AYU (An International Quarterly Journal of Research in Ayurveda). 2014 Jul 1;35(3):330-2.
  21. Mwitari PG, Ayeka PA, Ondicho J, Matu EN, Bii CC. Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera , Warbugia ugandensis, Prunus africana and Plectrunthus barbatus. PloS one. 2013 Jun 13;8(6):e65619.
  22. Dikasso D, Makonnen E, Debella A, Abebe D, Urga K, Makonnen W, Melaku D, Assefa A, Makonnen Y. In vivo anti-malarial activity of hydroalcoholic extracts from Asparagus africanus Lam. in mice infected with Plasmodium berghei. Ethiopian Journal of Health Development. 2006;20(2):112-8.
  23. Rojas NG, Cesarini ME, Peker G, Da Prat GA, Etcheverry JL, Gatto EM. Review of Huntington’ s Disease: From Basics to Advances in Diagnosis and Treatment. Journal of Neurology Research. 2022 Oct 22;12(3):93-113.
  24. Kumar P, Kumar A. Possible neuroprotective effect of Withania somnifera  root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. Journal of medicinal food. 2009 Jun 1;12(3):591-600.
  25. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera  supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition. 2015 Nov 25;12(1):43.
  26. Mohanty IR, Arya DS, Gupta SK. Withania somnifera  provides cardioprotection and attenuates ischemia–reperfusion induced apoptosis. Clinical Nutrition. 2008 Aug 1;27(4):635-42.
  27. Khalil MI, Ahmmed I, Ahmed R, Tanvir EM, Afroz R, Paul S, Gan SH, Alam N. Amelioration of isoproterenol?induced oxidative damage in rat myocardium by Withania somnifera  leaf extract. BioMed research international. 2015;2015(1):624159.
  28. Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Effect of Withania somnifera  (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integrative cancer therapies. 2013 Jul;12(4):312-22.
  29. Chopra A, Saluja M, Tillu G, Venugopalan A, Narsimulu G, Sarmukaddam S, Patwardhan B. Evaluating higher doses of Shunthi-Guduchi formulations for safety in treatment of osteoarthritis knees: A Government of India NMITLI arthritis project. Journal of Ayurveda and integrative medicine. 2012 Jan;3(1):38.
  30. Gannon JM, Forrest PE, Chengappa KR. Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera  in persons with bipolar disorder. Journal of Ayurveda and integrative medicine. 2014 Oct;5(4):241.
  31. Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. The Journal of Alternative and Complementary Medicine. 2018 Mar 1;24(3):243-8.
  32. Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. The Journal of pharmacy and pharmacology. 1998 Sep 1;50(9):1065-8.
  33. Gupta A, Mahdi AA, Shukla KK, Ahmad MK, Bansal N, Sankhwar P, Sankhwar SN. Efficacy of Withania somnifera  on seminal plasma metabolites of infertile males: a proton NMR study at 800 MHz. Journal of ethnopharmacology. 2013 Aug 26;149(1):208-14.
  34. Dongre S, Langade D, Bhattacharyya S. Efficacy and safety of Ashwagandha (Withania somnifera ) root extract in improving sexual function in women: a pilot study. BioMed research international. 2015;2015(1):284154.
  35. Mamidi P, Thakar AB. Efficacy of Ashwagandha (Withania somnifera  Dunal. Linn.) in the management of psychogenic erectile dysfunction. AYU (An International Quarterly Journal of Research in Ayurveda). 2011 Jul 1;32(3):322-8.
  36. Prasad Mamidi PM, Kshama Gupta KG, Thakar AB. Ashwagandha in psychogenic erectile dysfunction: ancillary findings.
  37. Bobade MT, Thorwat VK. Ashwagandha in treatment of insomnia: A review. Nat J. Res. Ayurved Sci. 2019;7.
  38. Langade D, Thakare V, Kanchi S, Kelgane S. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study. Journal of ethnopharmacology. 2021 Jan 10; 264:113276.
  39. Deshpande A, Irani N, Balkrishnan R, Benny IR. A randomized, double blind, placebo-controlled study to evaluate the effects of ashwagandha (Withania somnifera ) extract on sleep quality in healthy adults. Sleep medicine. 2020 Aug 1; 72:28-36.
  40. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D, Langade DG. Efficacy and safety of Ashwagandha (Withania somnifera ) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus. 2019 Sep 28;11(9).
  41. Salve J, Pate S, Debnath K, Langade D, Langade DG. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019 Dec 25;11(12).
  42. Anand U, Cabreros C, Mal J, Ballesteros Jr F, Sillanpää M, Tripathi V, Bontempi E. Novel coronavirus disease 2019 (COVID-19) pandemic: from transmission to control with an interdisciplinary vision. Environmental research. 2021 Jun 1; 197:111126.
  43. Alharbi RA. Structure insights of SARS-CoV-2 open state envelope protein and inhibiting through active phytochemical of ayurvedic medicinal plants from Withania somnifera . Saudi Journal of Biological Sciences. 2021 Jun 1;28(6):3594-601.
  44. Patil VS, Hupparage VB, Malgi AP, Deshpande SH, Patil SA, Mallapur SP. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera . Chinese Herbal Medicines. 2021 Jul 1;13(3):359-69.
  45. Parida PK, Paul D, Chakravorty D. Free energy landscapes and residue network analysis for six SARS-CoV-2 targets in complex with plausible phytochemical inhibitors from Withania somnifera : 1 µs molecular dynamics simulations.
  46. Kushwaha PP, Singh AK, Prajapati KS, Shuaib M, Gupta S, Kumar S. Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study. Microbial Pathogenesis. 2021 Aug 1; 157:104954.
  47. Tripathi MK, Singh P, Sharma S, Singh TP, Ethayathulla AS, Kaur P. Identification of bioactive molecule from Withania somnifera  (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics. 2021 Sep 2;39(15):5668-81.
  48. Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis and cartilage. 2015 Aug 1;23(8):1233-41.
  49. Meschini C, Cauteruccio M, Oliva MS, Sircana G, Vitiello R, Rovere G, Muratori F, Maccauro G, Ziranu A. Hip and knee replacement in patients with ochronosis: clinical experience and literature review. Orthopedic reviews. 2020 Jun 26;12(Suppl 1):8687.
  50. Musumeci G, Aiello FC, Szychlinska MA, Di Rosa M, Castrogiovanni P, Mobasheri A. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. International journal of molecular sciences. 2015 Mar 16;16(3):6093-112.
  51. da Costa BR, Pereira TV, Saadat P, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375: n2321. doi:10.1136/bmj.n2321.
  52. Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. A pilot, randomized, double?blind, placebo?controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytotherapy Research. 2019 May;33(5):1457-68.
  53. Singh D, Aggarwal A, Maurya R, Naik S. Withania somnifera  inhibits NF?κB and AP?1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytotherapy Research. 2007 Oct;21(10):905-13.
  54. Ganesan K, Sehgal PK, Mandal AB, Sayeed S. Protective effect of Withania somnifera  and Cardiospermum halicacabum extracts against collagenolytic degradation of collagen. Applied biochemistry and biotechnology. 2011 Oct;165(3):1075-91.
  55. Chopra A, Saluja M, Tillu G. Ayurveda–modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis. Journal of Ayurveda and integrative medicine. 2010 Jul;1(3):190.

Reference

  1. Naik GH, Priyadarsini KI, Satav JG, Banavalikar MM, Sohoni DP, Biyani MK, Mohan H. Comparative antioxidant activity of individual herbal components used in Ayurvedic medicine. Phytochemistry. 2003 May 1;63(1):97-104.
  2. Abdel-Wahhab KG, Mourad HH, Mannaa FA, Morsy FA, Hassan LK, Taher RF. Role of ashwagandha methanolic extract in the regulation of thyroid profile in hypothyroidism modeled rats. Molecular biology reports. 2019 Aug 15;46(4):3637-49.
  3. Monograph (2004) Withania somnifera . Altern.Med. rev.9/. 211-214 NMI -ashwagandha – A- Revi 1/pg
  4. Singh N, Bhalla M, de Jager P, Gilca M. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. African journal of traditional, complementary and alternative medicines. 2011;8(5S).
  5. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D, Langade DG. Efficacy and safety of Ashwagandha (Withania somnifera ) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus. 2019 Sep 28;11(9).
  6. Po?umackanycz M, Forencewicz A, Weso?owski M, Viapiana AA. The plant with proven health-promoting properties. Farm. Pol. 2020; 76:442-7.
  7. Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J. Steroidal lactones from Withania somnifera , an ancient plant for novel medicine. Molecules. 2009 Jul 3;14(7):2373-93.
  8. Zahiruddin S, Basist P, Parveen A, Parveen R, Khan W, Ahmad S. Ashwagandha in brain disorders: A review of recent developments. Journal of ethnopharmacology. 2020 Jul 15; 257:112876.
  9. Matsuda H, Murakami T, Kishi A, Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera  DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorganic & medicinal chemistry. 2001 Jun 1;9(6):1499-507.
  10. Bhattacharya SK, Satyan KS, Shibnath Ghosal SG. Antioxidant activity of glycowithanolides from Withania somnifera .
  11. John J. Therapeutic potential of Withania somnifera : A report on phyto-pharmacological properties. Int. J. Pharm. Sci. Res. 2014 Jun 1;5(6):2131-48.
  12. Pandit S, Chang KW, Jeon JG. Effects of Withania somnifera  on the growth and virulence properties of Streptococcus mutans and Streptococcus sobrinus at sub-MIC levels. Anaerobe. 2013 Feb 1; 19:1-8.
  13. John J. Therapeutic potential of Withania somnifera : A report on phyto-pharmacological properties. Int. J. Pharm. Sci. Res. 2014 Jun 1;5(6):2131-48.
  14. Dutta R, Khalil R, Green R, Mohapatra SS, Mohapatra S. Withania somnifera  (Ashwagandha) and withaferin A: Potential in integrative oncology. International journal of molecular sciences. 2019 Oct 25;20(21):5310.
  15. https://www.researchgate.net/figure/Chemical-structures-of-phytochemicals-from-Withania-somnifera-from-wwwChemSpidercom_fig3_354890919
  16. Atta-ur-Rahman AU, Samina Abbas SA, Dur-e-Shahwar DE, Jamal SA, Choudhary MI. New withanolides from Withania spp.
  17. Tursunova RN, Maslennikova VA, Abubakirov NK. Withanolides in the vegetable kingdom. Chemistry of natural compounds. 1977 Mar;13(2):131-8.
  18. Dar NJ, Hamid A, Ahmad M. Pharmacologic overview of Withania somnifera , the Indian Ginseng. Cellular and molecular life sciences. 2015 Dec;72(23):4445-60.
  19. Rasool M, Varalakshmi P. Immunomodulatory role of Withania somnifera  root powder on experimental induced inflammation: An in vivo and in vitro study. Vascular pharmacology. 2006 Jun 1;44(6):406-10.
  20. Bisht P, Rawat V. Antibacterial activity of Withania somnifera  against Gram-positive isolates from pus samples. AYU (An International Quarterly Journal of Research in Ayurveda). 2014 Jul 1;35(3):330-2.
  21. Mwitari PG, Ayeka PA, Ondicho J, Matu EN, Bii CC. Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera , Warbugia ugandensis, Prunus africana and Plectrunthus barbatus. PloS one. 2013 Jun 13;8(6):e65619.
  22. Dikasso D, Makonnen E, Debella A, Abebe D, Urga K, Makonnen W, Melaku D, Assefa A, Makonnen Y. In vivo anti-malarial activity of hydroalcoholic extracts from Asparagus africanus Lam. in mice infected with Plasmodium berghei. Ethiopian Journal of Health Development. 2006;20(2):112-8.
  23. Rojas NG, Cesarini ME, Peker G, Da Prat GA, Etcheverry JL, Gatto EM. Review of Huntington’ s Disease: From Basics to Advances in Diagnosis and Treatment. Journal of Neurology Research. 2022 Oct 22;12(3):93-113.
  24. Kumar P, Kumar A. Possible neuroprotective effect of Withania somnifera  root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. Journal of medicinal food. 2009 Jun 1;12(3):591-600.
  25. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera  supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition. 2015 Nov 25;12(1):43.
  26. Mohanty IR, Arya DS, Gupta SK. Withania somnifera  provides cardioprotection and attenuates ischemia–reperfusion induced apoptosis. Clinical Nutrition. 2008 Aug 1;27(4):635-42.
  27. Khalil MI, Ahmmed I, Ahmed R, Tanvir EM, Afroz R, Paul S, Gan SH, Alam N. Amelioration of isoproterenol?induced oxidative damage in rat myocardium by Withania somnifera  leaf extract. BioMed research international. 2015;2015(1):624159.
  28. Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Effect of Withania somnifera  (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integrative cancer therapies. 2013 Jul;12(4):312-22.
  29. Chopra A, Saluja M, Tillu G, Venugopalan A, Narsimulu G, Sarmukaddam S, Patwardhan B. Evaluating higher doses of Shunthi-Guduchi formulations for safety in treatment of osteoarthritis knees: A Government of India NMITLI arthritis project. Journal of Ayurveda and integrative medicine. 2012 Jan;3(1):38.
  30. Gannon JM, Forrest PE, Chengappa KR. Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera  in persons with bipolar disorder. Journal of Ayurveda and integrative medicine. 2014 Oct;5(4):241.
  31. Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. The Journal of Alternative and Complementary Medicine. 2018 Mar 1;24(3):243-8.
  32. Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. The Journal of pharmacy and pharmacology. 1998 Sep 1;50(9):1065-8.
  33. Gupta A, Mahdi AA, Shukla KK, Ahmad MK, Bansal N, Sankhwar P, Sankhwar SN. Efficacy of Withania somnifera  on seminal plasma metabolites of infertile males: a proton NMR study at 800 MHz. Journal of ethnopharmacology. 2013 Aug 26;149(1):208-14.
  34. Dongre S, Langade D, Bhattacharyya S. Efficacy and safety of Ashwagandha (Withania somnifera ) root extract in improving sexual function in women: a pilot study. BioMed research international. 2015;2015(1):284154.
  35. Mamidi P, Thakar AB. Efficacy of Ashwagandha (Withania somnifera  Dunal. Linn.) in the management of psychogenic erectile dysfunction. AYU (An International Quarterly Journal of Research in Ayurveda). 2011 Jul 1;32(3):322-8.
  36. Prasad Mamidi PM, Kshama Gupta KG, Thakar AB. Ashwagandha in psychogenic erectile dysfunction: ancillary findings.
  37. Bobade MT, Thorwat VK. Ashwagandha in treatment of insomnia: A review. Nat J. Res. Ayurved Sci. 2019;7.
  38. Langade D, Thakare V, Kanchi S, Kelgane S. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study. Journal of ethnopharmacology. 2021 Jan 10; 264:113276.
  39. Deshpande A, Irani N, Balkrishnan R, Benny IR. A randomized, double blind, placebo-controlled study to evaluate the effects of ashwagandha (Withania somnifera ) extract on sleep quality in healthy adults. Sleep medicine. 2020 Aug 1; 72:28-36.
  40. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D, Langade DG. Efficacy and safety of Ashwagandha (Withania somnifera ) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus. 2019 Sep 28;11(9).
  41. Salve J, Pate S, Debnath K, Langade D, Langade DG. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019 Dec 25;11(12).
  42. Anand U, Cabreros C, Mal J, Ballesteros Jr F, Sillanpää M, Tripathi V, Bontempi E. Novel coronavirus disease 2019 (COVID-19) pandemic: from transmission to control with an interdisciplinary vision. Environmental research. 2021 Jun 1; 197:111126.
  43. Alharbi RA. Structure insights of SARS-CoV-2 open state envelope protein and inhibiting through active phytochemical of ayurvedic medicinal plants from Withania somnifera . Saudi Journal of Biological Sciences. 2021 Jun 1;28(6):3594-601.
  44. Patil VS, Hupparage VB, Malgi AP, Deshpande SH, Patil SA, Mallapur SP. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera . Chinese Herbal Medicines. 2021 Jul 1;13(3):359-69.
  45. Parida PK, Paul D, Chakravorty D. Free energy landscapes and residue network analysis for six SARS-CoV-2 targets in complex with plausible phytochemical inhibitors from Withania somnifera : 1 µs molecular dynamics simulations.
  46. Kushwaha PP, Singh AK, Prajapati KS, Shuaib M, Gupta S, Kumar S. Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study. Microbial Pathogenesis. 2021 Aug 1; 157:104954.
  47. Tripathi MK, Singh P, Sharma S, Singh TP, Ethayathulla AS, Kaur P. Identification of bioactive molecule from Withania somnifera  (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics. 2021 Sep 2;39(15):5668-81.
  48. Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis and cartilage. 2015 Aug 1;23(8):1233-41.
  49. Meschini C, Cauteruccio M, Oliva MS, Sircana G, Vitiello R, Rovere G, Muratori F, Maccauro G, Ziranu A. Hip and knee replacement in patients with ochronosis: clinical experience and literature review. Orthopedic reviews. 2020 Jun 26;12(Suppl 1):8687.
  50. Musumeci G, Aiello FC, Szychlinska MA, Di Rosa M, Castrogiovanni P, Mobasheri A. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. International journal of molecular sciences. 2015 Mar 16;16(3):6093-112.
  51. da Costa BR, Pereira TV, Saadat P, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375: n2321. doi:10.1136/bmj.n2321.
  52. Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. A pilot, randomized, double?blind, placebo?controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytotherapy Research. 2019 May;33(5):1457-68.
  53. Singh D, Aggarwal A, Maurya R, Naik S. Withania somnifera  inhibits NF?κB and AP?1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytotherapy Research. 2007 Oct;21(10):905-13.
  54. Ganesan K, Sehgal PK, Mandal AB, Sayeed S. Protective effect of Withania somnifera  and Cardiospermum halicacabum extracts against collagenolytic degradation of collagen. Applied biochemistry and biotechnology. 2011 Oct;165(3):1075-91.
  55. Chopra A, Saluja M, Tillu G. Ayurveda–modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis. Journal of Ayurveda and integrative medicine. 2010 Jul;1(3):190.

Photo
Savita Tambe
Corresponding author

Genba Sopanrao Moze College of Pharmacy, Wagholi, Pune

Photo
Vishakha Tikute
Co-author

Genba Sopanrao Moze College of Pharmacy, Wagholi, Pune

Photo
Manasi Talape
Co-author

Genba Sopanrao Moze College of Pharmacy, Wagholi, Pune

Photo
Shraddha Sakharkar
Co-author

Genba Sopanrao Moze College of Pharmacy, Wagholi, Pune

Photo
Dr. Tushar Shelke
Co-author

Genba Sopanrao Moze College of Pharmacy, Wagholi, Pune

Savita Tambe, Vishakha Tikute, Manasi Talape, Shraddha Sakharkar, Dr. Tushar Shelake, Therapeutic Potential of Withania somnifera in Osteoarthritis, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 10, 214-228. https://doi.org/10.5281/zenodo.17250714

More related articles
Exploring The Cytoprotective Effect of Phyllanthus...
Sharvari Yadav, Satyashri Sargar , Bhagyashri Yamgar , Rutuja Bag...
Commencement Scrutiny Of 1,3,4-Oxadiazole; Its Vis...
Rachel Mathew, V .S. Anjana , Ayoona Najeeb , Fathima Shereen S, ...
In-Vitro wound healing activity using cell line by...
Mrs Sonali Gurav, Preeti Kale, Snehal Jamdade, Shreya kamble, Shu...
Related Articles
Wound Healing Potential of Adenanthera Pavonina On Alloxan Induced Diabetic Woun...
Roshni Gawande, Dr. Anjali Wankhade , Dr. Vivek Paithankar , ...
Advanced Chromatographic Techniques in Pharmaceutical Analysis...
Rahul Chaudhari, Shweta Suryawanshi , Sneha Chitkalwar , Janhavi Patil , Ujwala Gawali , Sanket Bira...
Pharmacological Values of Benzodiazepam: A Potent Sedative and Anticovulsant ...
Saurabh Sapnar, Swapnil Gaikwad, Vishal Gumnar, Aditi Fufane , ...
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
Exploring The Cytoprotective Effect of Phyllanthus Emblica (Amla Leaf)...
Sharvari Yadav, Satyashri Sargar , Bhagyashri Yamgar , Rutuja Bagade , Sharad Kamble , ...
More related articles
Exploring The Cytoprotective Effect of Phyllanthus Emblica (Amla Leaf)...
Sharvari Yadav, Satyashri Sargar , Bhagyashri Yamgar , Rutuja Bagade , Sharad Kamble , ...
Commencement Scrutiny Of 1,3,4-Oxadiazole; Its Visceral Activities ...
Rachel Mathew, V .S. Anjana , Ayoona Najeeb , Fathima Shereen S, Nikhila Anna Anil , Sarin Santhosh,...
In-Vitro wound healing activity using cell line by extraction of Cinnamomum tama...
Mrs Sonali Gurav, Preeti Kale, Snehal Jamdade, Shreya kamble, Shubham Patil, Arati Mali, Aishwarya ...
Exploring The Cytoprotective Effect of Phyllanthus Emblica (Amla Leaf)...
Sharvari Yadav, Satyashri Sargar , Bhagyashri Yamgar , Rutuja Bagade , Sharad Kamble , ...
Commencement Scrutiny Of 1,3,4-Oxadiazole; Its Visceral Activities ...
Rachel Mathew, V .S. Anjana , Ayoona Najeeb , Fathima Shereen S, Nikhila Anna Anil , Sarin Santhosh,...
In-Vitro wound healing activity using cell line by extraction of Cinnamomum tama...
Mrs Sonali Gurav, Preeti Kale, Snehal Jamdade, Shreya kamble, Shubham Patil, Arati Mali, Aishwarya ...